2C2818).
Introduction
The glycoprotein hormone erythropoietin (EPO) is the principal humoral regulator of erythropoiesis (1) . In adults the kidneys are the main site of EPO synthesis. EPO production rates are inversely related to oxygen availability, and control of production has been shown to operate predominantly at the level of EPO mRNA (2) (3) (4) (5) . The mechanisms that regulate renal EPO mRNA levels in an oxygendependent fashion are yet incompletely understood, in part owing to the fact that the type of cell producing EPO in the kidney has not been identified. Immunohistochemical detection of EPO is hampered by the lack of significant renal stores of the hormone and has yielded conflicting results (6) (7) (8) (9) . In recent years, most investigators, using in situ hybridization of EPO "A, have disqualified previous concepts that either glomerular or tubular cells further identify the type of cell containing EPO "A, a double-labeling protocol was established that permitted on the same tissue section both in situ hybridization for EPO mRNA and parallel immunolabeling of eao-S-nudeoudase , a surface marker of peritubular interstitial fibroblasts. The combined labeling technique revealed that a dear majority of cells expressing EPO mRNA also displayed staining for anti-5'-Nu. Staining for EPO mRNA was localized in central perinuclear parts of the interstitial cells, whereas 5'-Nu label was present on the cell surface, induding the cytoplasmic processes. These data indicate that peritubular fibroblasts are cellular sites for production of erythropoietin. (J Hisrochem Cytochem 41535-341, 1993) KEY WOW: Erythropoietin; In situ hybridization; Ecto-5'nucleotidase; Immunohistochemistry; Fibroblasts; Renal cortex; Rat. produce EPO. Using 31S-labeled probes, Lacombe et al. (10) and Koury et al. (11) have instead detected EPO mRNA in peritubular cells of the renal cortex and outer medulla of anemic mice. Similar results were subsequently obtained in rats (12, 13) , and in accordance with these findings, EPO mRNA was also detected in interstitial cells of human polycystic kidneys (14). Moreover, Koury et al. (15) have shown that the number of peritubular cells accumulating EPO mRNA increases with increasing severity of anemia, but that even under severe hypoxic stimulation EPO-producing cells represent only a subset of the total interstitial cell population. However, on the basis of purely morphological criteria, it has thus far not been possible to identlfy the type of interstitial cell that is responsible for the synthesis of EPO mRNA, although it has been speculated that, because of their location, peritubular endothelial cells were the most likely candidate (10,ll) . Apart from endothelia, however, the peritubular space of the renal cortex and outer medulla contains two other types of cells: bone marrow-derived interstitial cells and resident interstitial cells (16) . The group of bone marrowderived interstitial cells, although heteromorphic, is characterized by the presence of antigens of the major histocompatibility com-335 plex (MHC) I1 class (17) . Indirect evidence suggests that this latter group of cells plays no role in EPO formation, because their depletion after whole-body irradiation does not affect renal EPO production (18) . Resident interstitial cells, which have been termed fibrocytes or fibroblasts, are characterized by extended cytoplasmic processes. In the cortical labyrinth, they are further characterized by the presence of the membrane enzyme ecto-5'-nucleotidase (5'-Nu) (19) (20) (21) , which catalyzes the hydrolysis of 5'-AMP to adenosine. In the present study, advantage was taken of the possibility to specifically label the renal cortical fibroblasts by immunohistochemistry against 5'-Nu (20, 21) . We have used non-radioactive, high-resolution in situ hybridization of EPO mRNA on kidney specimens of anemic rats to detect EPO-producing cells in combination with immunohistochemistry against 5'-Nu by establishing a double-labeling technique.
Materials and Methods
Animals. Experiments were performed using nine male Sprague-Dawley rats (body weight 250-306 g), which were allowed free access to standard laboratory diet and tapwater. For induction of hemorrhagic anemia, in seven animals a catheter was inserted into the left carotid artery under briefanesthesia (methohexital, 100 mglkg body weight). Approximately 3 ml of blood were removed from the catheters at 2-hr intervals and replaced by endogenous rat plasma supplemented with Ringer solution until a target hematocrit of around 12% was achieved. Twenty-four hours later animals were anesthetized by an IP injection of sodium pentobarbital (40 mglkg body weight) and perfusion-fixed by cannulation of the abdominal aorta as described (22) . Five anemic and two control animals were perfused at a pressure of 220 mmlHg with 3% freshly prepared paraformaldehyde in PBS for 90 sec. At a reduced pressure of 60 mm/Hg. perfusion with the fixative was continued for another 4 min. To avoid freezing artifacts, subsequent rinsing was performed for 5 min at 60 mmlHg with a sucrose-PBS solution adjusted to 800 mOsmollkg. Kidneys were then removed and cut into slices (thickness approximately 3 mm) which were shock-frozen in liquid nitrogen-cooled isopentane. To compare EPO mRNA signal intensity in fixed and unfixed tissue, another two anemic animals were sacrificed without perfusion-fixation and kidneys were removed, cut into slices, and shockfrozen directly. At the time of sacrifice, hematocrit values ranged from Hybridization Probe. For preparation of the probe, a plasmid PAM 18 containing a 0.2 KB partial rat EPO cDNA fragment was used (kindly provided by Dr. P. J. Ratcliffe, Oxford, UK). The cDNA fragment had been generated by the polymerase chain reaction using primer sequences based on the mouse EPO gene sequence and comprised 60 BP of exon IV and 132 BP of exon V. It was subcloned into the SmaI site of the polylinker. The RNA probes were synthesized and labeled by in vitro transcription using digoxigenin-ll-UTP ("DIG~labeled nucleotide). For generation of an anti-sense probe, plasmids were linearized by KPN I and tr by T7 polymerase; for the sense probe, BAM H I and SP6 polyperase FK used. For transcription, 1 pg of linearized plasmid DNA'was incubated in transcription buffer [40 mM %is-HC1, pH 8.0, 6," MgC12, 10 mM NaCI, 6 mM dithiotreitol-(MT); 2 mM spermidine] with 750 pmol ATP, CTP, and GTP, 150 wmol UTP, 600-pmol DIG-ll-UTP, 1 UIp1 RNAse inhibitor, and 2 Ulpl T7 or SP6 RNA polymerase, respectively, at 37°C for 120 min. The DNA template was digested by addition of 1 
respective of the kind of tissue pre-treatment, the mounted sections were post-fixed in 4% paraformaldehyde in PBS (pH 7.2) for 25 min. After rinsing in PBS, slides were kept in 70% ethanol for up to 48 hr. For in situ hybridization, sections were hydrated in water. To reduce background reactivity, slides were acetylated with 0.1 M triethanolamine (pH 8.0) containing 0.25% acetic anhydride. Then 150 pI of pre-hybridization solution (50% deionized formamide, 50 mM Tris-HCI, pH 7.6, 25 mM EDTA, pH 8.0, 20 mM NaCI, 0.25 mglml yeast tRNA, 2.5 x Denhardt's solution) were applied per section for 2 hr at 41'C in a moist chamber. After removal of the pre-hybridization buffer, each section was covered with 20 pl of hybridization mixture [ 5 0 % deionized formamide, 0.1 M DTT, 20 mM Tris-HCI, pH 7.6, 0.3 M NaCI, 0.1 mglml poly-A, 1 x Denhardt's solution, 10% dextran sulfate as well as the appropriate concentration of labeled probe (0.5-5 ng per pl)]. Hybridization was performed in a moist chamber at 4 1 T for 16-18 hr. Washing was performed in 2 x standard saline citrate (SSC) without formamide for 30 min, followed by washes in SSC containing 50% formamide [I x SSC (1 hr, two changes); 0.5 x SSC(1-2 hr. three changes); and 0.1 x SSC (1 hr, two changes)] at either 48'C or 53°C. Subsequently, slides were rinsed in 0.1 x SSC at room temperature for 20 min (two changes), followed by two 10-min rinses in Buffer I(lO0 mM Tris-HC1, 150 mM NaCI, pH 7.5). Blocking of unspecific antibody binding sites was then performed by incubation with blocking medium (2% normal sheep serum, 0.5% bovine serum albumin, 3% Triton X-100 in Buffer I) for 30 min at room temperature. After removal of the blocking medium, sections were incubated with 40 pl sheep anti-DIG-alkaline phosphatase conjugate (1:500 in blocking medium) for 12-16 hr at 4°C in a moist chamber. Slides were then washed for 30 min (three changes) in Buffer I, rinsed briefly in Buffer I1 (100 mM Tris-HC1, 100 mM NaCI, 50 mM MgC12, pH 9.5), and subsequently equilibrated in this buffer for 10 min. Detection of the sig nal was performed by adding 150 p1 chromogen solution per slide [45 pI nitroblue tetrazolium (75 mglml in 70% dimethylformamide) and 35 pl 5-bromo-4-chloro-3-indoly1-phosphate (50 pglml in 100% dimethylformamide) in 10 ml Buffer 111 in a moist chamber at room temperature. Slides were checked for color development and the reaction was stopped by immersing the slides in 10 mM Tris-HCI with 1 mM EDTA, pH 8.0, for 10 min. Slides were then rinsed in PBS for 10 min and coverslipped with phosphate-buffered glycerol. Water used in all preparations was from an ultrafiltration device (Seralpur; Alhauser, Ransbach, Germany) and contained no RNAse inhibitor.
Immunohistochemistry. In an attempt to label peritubular capillaries, a mouse monoclonal antibody against factor-VIII-related antigen (Dakopatts; Glostrup, Denmark) was used. For labeling of peritubular interstitial fibroblasts, we used a rabbit polyclonal antibody to purified rat renal ecto->'-nucleotidase (S'-Nu) (19, 24) . Cryostat sections (5 pm) were thawed onto chrome-gelatin-coated glass slides (0.5 Yo chromalum, 0.5 Oh gelatin in water). For indirect immunofluorescence labeling, the slides were first treated with 10% normal swine serum in PBS to reduce nonspecific antibody binding. This was blotted away and the sections were then incubated with immune serum at a dilution of 1:50 to 1:2000 for 12-18 hr at 4°C in a moist chamber. Sections were subsequently washed in PBS for 30 min (two changes). For detection of the bound antibody, a biotin-streptavidin-Texas red fluorescent labeling complex was used. Sections were incubated with avidin-coupled anti-rabbit IgG or anti-mouse IgG (1:50 in PBS) for 2 hr at room temperature, rinsed for 30 min in PBS (two changes), and then incubated with streptavidin-Texas red (1:50 in PBS) for 2 hr at room temperature. After two further washes in PBS (30 min), slides were coverslipped with phosphate-buffered glycerol.
free DNAse I for 20 min at 37'C. Transcripts were isolated by ethanol precipitation and checked for Probe length formaldehYde-wm elecuophoresis and ethidium bromide staining.
In Situ Hybridization. To localize EPO mRNA in the kidney, 5-7 pm thick cryostat sections were thawed onto silane-coated glass slides (23) . Ir-Combination of In Situ Hybridization and Immunohistochemistry. For double application of EPO RNA probe and one of the specific antibodies to the same tissue section, a combined labeling protocol was established on cryostat sections that first went through the regular in situ hybridization protocol as described above. After removal of the blocking medium preceding the incubation with anti-Dig-alkaline phosphatase conjugate, however, a mixture of both sheep anti-DIG conjugate and one of the specific antibodies was diluted in blocking medium (dilution of anti-DIG conjugate was 1:500, dilution of the other antibodies was 1:50 to 1:200). This mixture was administered to the sections for 1 hr at room temperature, followed by 12-18 hr at 4'C in a moist chamber. Slides were then rinsed for 30 min (two changes) in Buffer I. Subsequently, the detection components for the specific antibodies were administered using indirect immunofluorescence labeling with the biotin-streptavidin-Texas red detection system as described above. After the incubation step with streptavidin-Tmas red. slides were rinsed for 30 min in Buffer I (two changes). For subsequent visualization of bound anti-DIG-phosphatase conjugate, slides were briefly rinsed and equilibrated in Buffer I1 (before the chromogen solution) and were then processed exactly as described in the regular in situ hybridization protocol (see above). The quantity of antiserum and detection compounds applied per section was 40 pl throughout all steps,unless otherwise stated.
Controls.
Alternate sections labeled with sense probes for in situ hybridization were added in all experiments and processed in parallel to anti- sense-labeled sections. Specificity of the immunohistochemical signal had been well established previously with the antibody used in this study (21); therefore. controls were limited to rcplacement of the specific antibody by normal rabbit serum in Buffer I.
Microscopy. Slides were viewed in a Reichert Polyvar I1 light microscope equipped with cpifluorcscence illumination und interference contrast optics.
Reagents and Chemicals. Restriction enzymes were from Gibco (Eggenstein. Germany) and RNA polymerases were from Promega (Madison, WI). The biotin-streptavidin-Texas red fluorescent labeling complcx was from Amersham (Braunschwcig, Gcrmany). Anti-DIG-alkaline phosphat a x conjugate. DIG-labeled nucleotida, and the remaining molecular chcmicals were from Bochringer (Mannhcim, Germany).
Results
Non-radioactive in situ hybridization was applied to cryostat sections from both native and perfusion-fixed kidneys of rats made anemic by repeated bleeding (final hematocrit 12-16%) and control animals. For hybridization, a digoxigenin-UTF-labeled EPO cRNA probe was used. Hybridized RNA was detected with an antidigoxigenin-phosphatase conjugate and nitroblue tetrazolium as a substrate, yielding a brown precipitate. Positive staining was reproducibly detected after hybridization with anti-sense probe; no specific hybridization signal was detected when a sense rat EPO cRNA was used on alternate sections under identical conditions.
As shown in Figure 1 on a low-magnification micrograph of the cortex from native renal tissue of an anemic rat, cells staining for the presence of EPO mRNA were found exclusively in a peritubular position. No signals were present in the renal medulla (not shown) and over glomerular or tubular cells of the cortex. Further-more, no hybridization signals were observed in association with intrarenal arteries, arterioles, and veins. Peritubular cells containing EPO mRNA were frequently associated in clusters and were predominantly located in deep and midcortical areas; however, clusters of positive cells were also present in superficial areas of the cortex.
The use of perfusion-fixed tissue permitted higher structural resolution, particularly of the renal interstitium, as demonstrated in Figure 2 , but was accompanied by some reduction in sensitivity, i.e., in the number of positively hybridized cells. With the aid of high-resolution interference contrast optics we found that cells expressing EPO mRNA were typically located in the angles between adjacent tubules or between tubules and vessels. These spaces are predominantly occupied by resident interstitial fibroblasts and their cytoplasmic processes. In contrast to kidneys from anemic rats, in kidneys from animals with normal hematocrit only very few positively hybridized cells were occasionally detected in deep cortical areas.
To provide further evidence for the origin of cells accumulating EPO mRNA during anemia, we aimed to use certain cellular markers for the identification of subclasses of peritubular cells and to combine immunohistochemistry against these markers with in situ hybridization for EPO mRNA on the same tissue section. Factor VIII-related antigen (FRA) was studied as a potential marker of endothelial cells and ecto-5'-nucleotidase (5'-Nu) was used to identify peritubular fibroblasts. Bound antibody was detected by a biotinylated "bridging" antibody and an avidin-coupled fluorescent dye.
Anti-FRA immunostaining showed an intensive staining of endothelial cells lining arteries, arterioles, and larger veins, whereas the majority of peritubular capillaries displayed only faint and irregularly distributed staining (results not shown). In fact, capillary labeling was too weak to be reliably detected when immunohistochemistry against FRA was combined with in situ hybridization of EPO mRNA. In contrast, immunohistochemistry against 5'-Nu revealed an intense staining of a subset of the peritubular cells, including extensive cytoplasmic processes of these cells (Figure 3B ). In addition, the presence of this enzyme was detectable on the proximal tubule brush border.
When immunohistochemistry against 5'-Nu was performed on the same section in parallel with in situ hybridization of EPO mRNA. we found that the vast majority of hybridization signals could be clearly assigned to cells that also displayed staining for anti-Y-Nu. Figure 3A shows the in situ hybridization corresponding to the immunofluorescence shown in Figure 3B . Staining for EPO mRNA was localized in central perinuclear parts of the interstitial cells, whereas 5'-Nu labeling was concentrated on the cell surface, including the cytoplasmic processes, extending between adjacent tubules or between vessels and tubules. Therefore, the combined labeling resulted. in fact, in a complementary staining pattern in those peritubular cells that were recognized by either labeling protocol. In some cells containing EPO mRNA, however, the reaction product of the hybridization was only in part surrounded by the fluorescent signal from immunohistochemistry against 5'-Nu, so that in these cells the congruent staining pattern could in theory arise from cell processes of adjacent S'-Nu-positive cells. A clear majority of hybridization signals was, however, completely sur- (Figure 4) . indicating that the enzyme was present on the surface of EPO-producing cells. In only a few cases, EPO mRNA-containing cells revealed partial or no 5'-Nu staining. To quantify the frequency of co-staining of EPO mRNA with 5'-Nu, 317 cells containing EPO mRNA were counted on paired high-power interference contrast and immunofluorescence photomicrographs from various areas of the renal cortex of different animals. In 68.4% of the cells containing EPO mRNA. a clear double labeling was evident. as the hybridization signal was completely surrounded by the immunoreactive exterior of a 5'-Nu-positivc cell. In 17.9% of the cells only partial surrounding of the hybridization signal with the fluorescent signal was seen, and in 13.7% of the cells immunoreactivity was too weak or absent and could therefore not be clearly identified in association with EPO mRNA. In the latter two cases, howevcr, the in situ hybridization signal was often stronger than elsewhere and may therefore have extinguished the immunocytochemical signal. Conversely. when the number of 5'-Nu-positivc cells containing EPO mRNA was compared with the overall frequency of peritubular cells showing 5'-Nu labeling. it became obvious that only a subset of less than 20% of these cells accumulate EPO mRNA (Figure 3) .
The majority of cells staining for EPO mRNA were not associated with a capillary lumen ( Figure 4A ). In many instances. endothelial cells could be identified in interference contrast. as they were bulging into the lumen of larger peritubular capillaries. These cells were routinely negative with either labeling technique. Occasionally, cells containing EPO mRNA were found adjacent to endothelial cells but farther away from the capillary lumen.
Discussion
The localization of EPO mRNA in peritubular cells of the renal COKCX. as demonstrated in this study with non-radioactive in situ hybridization. is in accordance with previous reports by Lacombe et al. (10) and Koury et al. (11) . who used 35S-labeled cDNA or cRNA probes. Our mults an in contrast, howcver. to those by Maxwell et al.. who reported the presence of EPO mRNA in tubular cells (9) . but. as discussed previously (25) . the use of 32P-labeled oligonucleotide probes on thick cryosmions by these investigators may be less favorable for molving EPO gene expression at the cellular Iml. Rcprding the identity of the peritubular cells containing EPO mRNA. our findings suggest that they are at least to a major pan fibroblasts. The use of a double-labeling technique enabled us to combine on the same sections in situ hybridization of EPO mRNA and immunohistochemistry against 5'-Nu. a surface marker of peritubular fibroblasts, and rcvcalcd an obvious colocalization of both pameters. In accordance with this. we found that the majority ofcclls containing EPO mRNA were not associated with a capillary lumen. In contrast to previous investigations by Koury et al. and Lacombe et al.. who used immersion-fixed tissue (10.11,15) . peritubular capillaries were easily identifiable in our specimens that had undergone high-pressure perfusion-fixation. The use of highly resolving interference contrast microscopy on hybridized, unstained sections permitted a clear identification of perinuclear areas of endothelial cells in many instances. None of these cells. however. contained EPO mRNA.
With regard to the co-localization of EPO mRNA and 5'-Nu immunoreactivity in the same peritubular cell type. it is of interest that recent studies showed marked morphological alterations of peritubular fibroblasts during chronic hypoxia. In anemic rats, irrespective of whether anemia was induced by autoimmunization against EPO (12) , or by hemolysis in combination with whole-body irradiation (26) , enlargement of these cells was observed along with an increase in the number of their cytoplasmic processes (12, 26) . Furthermore, the activity of the membrane enzyme >'-Nu in these cells was strongly increased in anemic animals, whereas no change in the activity of the same enzyme was observed on tubule brush borders (12, 26) . Whether the cellular mechanisms leading to these morphological alterations are related to the signal transduction that determines oxygen-dependent EPO formation is, however, unknown.
The occasional absence of double staining in EPO mRNAcontaining cells might be due to technical reasons based, for instance, on an overlap of the in situ hybridization signal over the immunohistochemical label. However, it cannot be excluded with certainty that in addition to fibroblasts another peritubular cell type participates in the production of EPO. That EPO production by two different cell types within the same organ is possible has recently been shown by Schuster et al. and by Koury et al., who found that in the liver both parenchymal and nonparenchymal cells express the EPO gene (13,27). Nevertheless, our results provide strong evidence that at least a vast majority of EPO mRNA expressing cells are also 5'-Nu positive and can therefore be regarded as interstitial fibroblasts. Clearly, however, only the minority of the peritubular cells expressing 5'-Nu contained EPO mRNA. Although the use of perfusion-fixed tissue in this study was found to reduce the sensitivity of EPO mRNA hybridization, this is in accordance with previous observations by Koury et al. (15) , who estimated that even in severe anemia less than 10% of the total interstitial cell population of the renal cortex contains measurable amounts of EPO "A.
It therefore remains to be investigated whether EPO production is restricted to a specialized, yet undefined subset of >'-Nupositive cells or whether local factors in the environment of peritubular fibroblasts, such as local oxygen tension or humoral signals, induce expression of the EPO gene in some but not all of these cells.
